Ciforadenant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ciforadenant, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma. [Phase 1, Phase 2]